Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease

Withdrawn before enrolling · Not applicable

Conditions studied: Breast Cancer

In brief

The purpose of this study is to evaluate whether high-resolution magnetic resonance imaging of the axilla with spectroscopy can identify nodal features suggestive of metastatic involvement in patients diagnosed with invasive breast cancer. This may enable us to define a select group of patients for whom axillary lymph node dissection could be avoided.

Key facts

Study ID

NCT00312637

Run by

UNC Lineberger Comprehensive Cancer Center

People needed

0

Starts

2005-03-01

Expected to finish

2008-03-01

Last updated by the study team

2012-05-01

Who can join

Age: 25 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with recent (within 60 days) invasive breast cancer.
• No previous ipsilateral axillary surgery.

You may not qualify if…

• Patients diagnosed with in situ disease.
• Patients with previous ipsilateral axillary surgery.
• Patients with MRI/MRA contraindications such as a cardiac pacemaker, an aneurysm clip, cochlear implants, and metal in the eyes.
• Patients who have had a moderate or severe contrast reaction to intravenous gadolinium-DTPA.
• Patients who are clinically not stable.
• Patients who cannot give consent.

Where it is running

• Mammography Clinic - UNC Hospitals — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.